The family physician, a dying breed, already replaced by better paid second- and third-line technical specialists then proactive laboratory-based preventive measures based on schedules to screen for anomalies in plasma molecules, in body images and soon in genetic material that treat the “molecules” rather than the patient — all to address risks that are almost certainly exaggerated.